Related Experiment Video
Updated: Jun 15, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Severe H1N1-Associated acute respiratory distress syndrome: A case series
Andrew R Lai1, Kevin Keet, Celina M Yong
1University of California, San Francisco, 94143-0131, USA. alai@medicine.ucsf.edu
Background:
Acute respiratory distress syndrome resulting from novel influenza A virus (H1N1) infection remains uncommon.
Methods:
We describe the clinical profiles of adult patients with acute respiratory distress syndrome due to microbiologically confirmed H1N1 admitted to a medical intensive care unit in San Francisco, California over a 2-month period.
Results:
Between June 1 and July 31, 2009, 7 patients (age range: 25-66 years; 4 patients under the age of 40 years; 6 male; 1 pregnant) were diagnosed with H1N1, with 5 of 6 (83%) having initial false-negative rapid testing. All developed respiratory failure complicated by acute respiratory distress syndrome, with 4 additionally developing multiorgan dysfunction. All were managed with a lung protective ventilator strategy (average number of days on the ventilator: 16), and 4 patients also required additional rescue therapies for refractory hypoxemia, including very high positive end-expiratory pressure, inhaled epoprostenol, recruitment maneuvers, and prone positioning. Despite these measures, 3 patients (43%) ultimately died.
Conclusions:
Clinicians should be vigilant for the potential of H1N1 infection to progress to severe acute respiratory distress syndrome in a variety of patient demographics, including younger patients without baseline cardiopulmonary disease. A high degree of suspicion is critical, especially with the relative insensitivity of rapid testing, and should prompt empiric antiviral therapy.
Insights
Novel influenza A virus (H1N1) can cause severe acute respiratory distress syndrome (ARDS) even in young, healthy individuals. High suspicion and prompt antiviral therapy are crucial due to unreliable rapid testing.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Acute respiratory distress syndrome (ARDS) from novel influenza A virus (H1N1) is uncommon.
- H1N1 infection poses a risk for severe respiratory complications.
Purpose of the Study:
- To describe the clinical characteristics of adult patients with H1N1-induced ARDS.
- To highlight the challenges in diagnosing and managing severe H1N1 cases.
Main Methods:
- Retrospective case series of 7 adult patients with confirmed H1N1 and ARDS.
- Analysis of clinical profiles, management strategies, and outcomes.
Main Results:
- Most patients were male and younger than 40; 83% had false-negative initial rapid tests.
- All developed respiratory failure and ARDS; 4 had multiorgan dysfunction.
- Lung protective ventilation and rescue therapies were used; 43% mortality rate.
Conclusions:
- Vigilance for H1N1 progressing to severe ARDS is essential across diverse demographics.
- High clinical suspicion is critical, especially given rapid test insensitivity.
- Empiric antiviral therapy should be considered promptly.
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Respiratory Syncytial Virus Disease